Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY:BDX)

207.85 +0.43 (+0.21%)
Streaming Delayed Price Updated: 11:01 AM EST, Jan 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
Schlumberger, Stellantis And ASML Holding Are Among Top 10 Large Cap Losers Last Week (July 14-July 18): Are The Others In Your Portfolio? ↗
Elevance Health and Waters led the weekly large-cap losers, hit by weak earnings, lowered guidance, and analyst downgrades. 
Via Benzinga
News headline image
The Smartest Dividend Stock to Buy With $1,000 Right Now ↗
Via The Motley Fool
News headline image
How Do Investors Really Feel About Becton Dickinson? ↗
 
Via Benzinga
News headline image
Market Monitor News July 15 BMO (Crypto stocks UP - Waters DOWN) ↗
Calm Before the Storm? Wall Street Holds Its Breath Ahead of Earnings and Inflation Bombshells 
Via Chartmill
Topics Economy
News headline image
How Is The Market Feeling About Becton Dickinson? ↗
 
Via Benzinga
News headline image
Q1 Rundown: BD (NYSE:BDX) Vs Other Surgical Equipment & Consumables - Diversified Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Monogram Technologies Inc. (Nasdaq - MGRM), Veritex Holdings, Inc. (Nasdaq - VBTX), ESSA Pharma Inc. (Nasdaq - EPIX), Waters Corporation (NYSE - WAT)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Becton's Biosciences And Diagnostics Arm Slated To Join Waters In $17.5 Billion Merger ↗
BD to spin off its diagnostics and biosciences business in a $17.5 billion merger with Waters, targeting $345 million in synergies by 2030. 
Via Benzinga
News headline image
1 Large-Cap Stock Worth Investigating and 2 to Think Twice About
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... 
Via StockStory
News headline image
The Best High Yield Medical Device Stock to Invest $1,000 in Right Now ↗
Via The Motley Fool
News headline image
3 of Wall Street’s Favorite Stocks with Mounting Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 to Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
News headline image
Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now ↗
Becton Dickinson stock (BDX): Signs point toward continued underperformance until early June 2027. 
Via Benzinga
News headline image
New Jersey Rep. Thomas Kean Bought Over $4K Worth of Amazon.com Stock: Here's What You Should Know ↗
 
Via Benzinga
News headline image
3 Healthcare Stocks Skating on Thin Ice
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
3 Value Stocks Facing Headwinds
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
News headline image
Accenture To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
6 Analysts Have This To Say About Becton Dickinson ↗
 
Via Benzinga
News headline image
3 Dawdling Stocks with Questionable Fundamentals
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
BDX Q1 Earnings Call: Missed Revenue Expectations, Margin Expansion, and Strategic U.S. Investments
Medical technology company Becton, Dickinson and Company (NYSE:BDX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 4.5% year on year to $5.27 billion. On the other hand, the... 
Via StockStory
Topics Economy World Trade
News headline image
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030 ↗
Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job creation across states. 
Via Benzinga
News headline image
Only Half Of S&P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards? ↗
Only about 50% of S&P 500 stocks trade above their 200-day average, signaling narrow breadth even as the index rallies 22% since April. 
Via Benzinga
Topics Stocks
News headline image
3 Profitable Stocks with Questionable Fundamentals
A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
News headline image
FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight ↗
FDA to increase surprise inspections at foreign facilities as U.S. companies pour billions into domestic drug and device manufacturing. 
Via Benzinga
News headline image
Block, Becton Dickinson And Pilgrim's Pride Are Among Top 10 Large-Cap Losers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? ↗
 
Via Benzinga
News headline image
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years ↗
Becton Dickinson receives multiple downgrades as analysts cite weakening organic growth and trimmed price targets following a Q2 update. 
Via Benzinga
News headline image
Wall Street Fully Recoups Tariff-Led Losses, Economy Contracts In First Quarter Yet April Payrolls Remain Strong: This Week In Markets ↗
 
Via Benzinga
Topics Economy
News headline image
Wall Street Roars Back From April Tariff Sell-Off: Which Sectors Are Still Underwater? ↗
 
Via Benzinga
News headline image
This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗
 
Via Benzinga
News headline image
Stock Of The Day – Bullish Capitulation In Becton, Dickinson? ↗
Shares of Becton, Dickinson (BDX) staged a large selloff yesterday. There may have been a capitulation. This could be bullish for the stock. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.